Pinnacle Financial Partners Inc Amphastar Pharmaceuticals, Inc. Transaction History
Pinnacle Financial Partners Inc
- $4.92 Billion
- Q3 2024
A detailed history of Pinnacle Financial Partners Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 1,000 shares of AMPH stock, worth $39,390. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$39,390
Previous $40,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
34.9MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$234 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$107 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$84.1 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$76.7 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$63.6 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.93B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...